GATA4 Deletions Associated with Congenital Heart Diseases in South Brazil

Abstract

The normal development of the heart comprises a highly regulated machinery of genetic events, involving transcriptional factors. Congenital heart disease (CHD), have been associated with chromosomal abnormalities and copy number variants (CNVs). Our goal was to investigate through the multiplex ligation-dependent probe amplification (MLPA) technique, the presence of CNVs in reference genes for normal cardiac development in patients with CHD. GATA4, NKX2–5, TBX5, BMP4, and CRELD1 genes and 22q11.2 chromosome region were analyzed in 207 children with CHD admitted for the first time in a cardiac intensive care unit from a pediatric hospital. CNVs were detected in seven patients (3.4%): four had a 22q11.2 deletion (22q11DS) (1.9%), two had a GATA4 deletion (1%) and one had a 22q11.2 duplication (0.5%). No patients with CNVs in the NKX2–5, TBX5, BMP4, and CRELD1 genes were identified. GATA4 deletions appear to be present in a significant number of CHD patients, especially those with septal defects, persistent left superior vena cava, pulmonary artery abnormalities, and extracardiac findings. GATA4 screening seems to be more effective when directed to these CHDs. The investigation of CNVs in GATA4 and 22q11 chromosome region in patients with CHD is important to anticipating the diagnosis, and to contributing to family planning.

Keywords

heart defects - congenital - GATA4 transcription factor - 22q11 deletion syndrome

Authors' Contributions

M.A.F., A.B.G., L.E.D., G.A., and P.R.G.Z. performed genetic testing and prepared the manuscript; M.A.F., G.A., and P.R.G.Z. supervised genetic testing; M.A.F., A.B.G., and R.F.M.R. reviewed clinical data and edited the manuscript; M.A.F., A.B.G., L.E.D., reviewed the medical records; M.A.F., R.F.M.R., and P.R.G.Z. designed the study, supervised genetic tests, wrote and edited the manuscript.

Publikationsverlauf

Eingereicht: 24. April 2020

Angenommen: 10. Juni 2020

Artikel online veröffentlicht:
29. Juli 2020

• References

• 1 Hoffman JIE, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002; 39 (12) 1890-1900
• 2 Bruneau BG. The developmental genetics of congenital heart disease. Nature 2008; 451 (7181): 943-948
• 3 Blue GM, Kirk EP, Sholler GF, Harvey RP, Winlaw DS. Congenital heart disease: current knowledge about causes and inheritance. Med J Aust 2012; 197 (03) 155-159
• 4 Garg V, Kathiriya IS, Barnes R. et al. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 2003; 424 (6947): 443-447
• 5 Kinnunen S, Välimäki M, Tölli M. et al. Nuclear receptor-like structure and interaction of congenital heart disease-associated factors GATA4 and NKX2–5. PLoS One 2015; 10 (12) e0144145
• 6 Matsuoka R. GATA4 mutation and congenital cardiovascular diseases: importance of phenotype and genetic background clarification. J Mol Cell Cardiol 2007; 43 (06) 667-669
• 7 Srivastava D. Genetic regulation of cardiogenesis and congenital heart disease. Annu Rev Pathol 2006; 1: 199-213
• 8 Simmons MA, Brueckner M. The genetics of congenital heart disease… understanding and improving long-term outcomes in congenital heart disease: a review for the general cardiologist and primary care physician. Curr Opin Pediatr 2017; 29 (05) 520-528
• 9 Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002; 30 (12) e57
• 10 Rosa RF, Pilla CB, Pereira VL. et al. 22q11.2 deletion syndrome in patients admitted to a cardiac pediatric intensive care unit in Brazil. Am J Med Genet A 2008; 146A (13) 1655-1661
• 11 Botto LD, Correa A, Erickson JD. Racial and temporal variations in the prevalence of heart defects. Pediatrics 2001; 107 (03) E32
• 12 Pohovski LM, Dumic KK, Odak L, Barisic I. Multiplex ligation-dependent probe amplification workflow for the detection of submicroscopic chromosomal abnormalities in patients with developmental delay/intellectual disability. Mol Cytogenet 2013; 6 (01) 7
• 13 El Malti R, Liu H, Doray B. et al. A systematic variant screening in familial cases of congenital heart defects demonstrates the usefulness of molecular genetics in this field. Eur J Hum Genet 2016; 24 (02) 228-236
• 14 Sørensen KM, El-Segaier M, Fernlund E. et al. Screening of congenital heart disease patients using multiplex ligation-dependent probe amplification: early diagnosis of syndromic patients. Am J Med Genet A 2012; 158A [phone]
• 15 Monteiro RAC, de Freitas ML, Vianna GS. et al. Major contribution of genomic copy number variation in syndromic congenital heart disease: the use of MLPA as the first genetic test. Mol Syndromol 2017; 8 (05) 227-235
• 16 Campos CM, Zanardo EA, Dutra RL, Kulikowski LD, Kim CA. Investigation of copy number variation in children with conotruncal heart defects. Arq Bras Cardiol 2015; 104 (01) 24-31
• 17 Liu Z, Wang J, Liu S. et al. Copy number variation of GATA4 and NKX2-5 in Chinese fetuses with congenital heart disease. Pediatr Int 2015; 57 (02) 234-238
• 18 Aguayo-Gómez A, Arteaga-Vázquez J, Svyryd Y. et al. Identification of Copy Number Variations in Isolated Tetralogy of Fallot. Pediatr Cardiol 2015; 36 (08) 1642-1646
• 19 Mutlu ET, Aykan HH, Karagöz T. Analysis of gene copy number variations in patients with congenital heart disease using multiplex ligation-dependent probe amplification. Anatol J Cardiol 2018; 20 (01) 9-15
• 20 Ang YS, Rivas RN, Ribeiro AJS. et al. Disease model of GATA4 mutation reveals transcription factor cooperativity in human cardiogenesis. Cell 2016; 167 (07) 1734-1749.e22
• 21 Wenger TL, Miller JS, DePolo LM. et al. 22q11.2 duplication syndrome: elevated rate of autism spectrum disorder and need for medical screening. Mol Autism 2016; 7: 27
• 22 Mattapally S, Nizamuddin S, Murthy KS. et al. c.620C>T mutation in GATA4 is associated with congenital heart disease in South India. BMC Med Genet 2015;16(07). Available at: https://doi.org/10.1186/s12881-015-0152-7
• 23 Mattapally S, Singh M, Samba Murthy K, Asthana S, Banerjee SK. Computational modeling suggests impaired interactions between NKX2.5 and GATA4 in individuals carrying a novel pathogenic D16N NKX2.5 mutation. Oncotarget 2018; 9: 13713-13732